
Opinion|Videos|May 29, 2024
Overcoming Barriers to Better Patient Outcomes in PAH
Author(s)Ronald Oudiz, MD, FACP, FACC, FCCP
Ronald Oudiz, MD, FACP, FACC, FCCP, discusses the challenges and limitations associated with the adoption of new treatments and the impact of emerging therapies on patient outcomes, quality of life, and disease management in the long term.
Advertisement
Episodes in this series

Video content above is prompted by the following questions:
- What are the potential challenges or limitations associated with the adoption of new treatments, such as cost, access, or safety concerns?
- How might the evolving treatment landscape for PAH impact patient outcomes, quality of life, and disease management in the long term?
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
After Narrow Miss in Phase 3 Study, IO Biotech Ponders Next Steps for Immune-Modulatory, Off-the-Shelf Cancer Vaccine
2
Ongoing COVID-19 Circulation Linked to Increases in Health-Related Work Absences, Workforce Exits
3
Guidelines for Bronchiectasis Highlight Multiple Treatment Methods
4
3 New Study Findings to Look Out for at Menopause Society 2025
5